HLA DR/DQ alleles and risk of type I diabetes in childhood: a population-based case-control study

被引:14
作者
Altobelli, E
Blasetti, A
Petrocelli, R
Tumini, S
Azzarone, R
Tiberti, S
Battistoni, C
Merante, D
Verrotti, A
Fioroni, MA
Iannarelli, R
Poccia, G
Papola, F
机构
[1] Univ Aquila, Chair Epidemiol, Dept Internal Med & Publ Hlth, I-67100 Laquila, Italy
[2] Univ Chieti, Chair Paediat, Fac Med, Chieti, Italy
[3] Reg Ctr Immunohaematol & Tissue Typing, Laquila, Italy
[4] Univ Aquila, Chair Hyg, Fac Med, Laquila, Italy
[5] St Chiara Hosp, Inst Clin Med, Pisa, Italy
[6] Ctr Diabet, Laquila, Italy
关键词
HLA haplotypes; type I diabetes mellitus; case-control study; population register; Abruzzo region;
D O I
10.1007/s10238-005-0069-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The objective was to evaluate HLA DR/DQ alleles and their risk factor for type 1 diabetes in the Abruzzo region (central Italy). Sixty incident cases from the Abruzzo region were studied together with 120 unrelated control subjects living in the same administrative areas. The relative risk of diabetes associated with the alleles under study was calculated by deriving the odds ratio (OR) maximum likelihood estimates and their 95% confidence intervals (Cl) by the exponentiation of the logistic regression beta-parameter. The combination DRB1*03/DQA1*0501/DQB1*0201 was found in 20.0% of patients and 7.1% of the control subjects, conferring an OR of 4.04 and a CI of 1.97-8.49. The combination DRB1*04/DQA1*0301/DQB1*0302 was found in 23.3% of diabetic patients and 6.7% of controls, giving an OR of 5.69 and a Cl of 2.77-12.05. DRB1*11/DQA1*0505/DQB1 *0301 and DQA1*0505/DQB1*0301 were negatively associated with type I diabetes (OR=0.27, CI 0.11-0.57; OR=0.07, Cl 0.02-0.19). The DQA1 genotype at risk was found to be DQA1*0301/DQA1*0501: OR=23.80, Cl 2.97-190.89, as it occurred with the highest frequency in the patient group. The DQB1 genotype at risk was found to be DQB1*0201/DQB1*0302, which occurred in 13.3% of patients but in only 1.1% of the control group (OR=29.75, Cl 5.36-549.25). Our results shed further light on the risk of development of this disease during a specific time period in an area where the overall incidence of type 1 diabetes is known.
引用
收藏
页码:72 / 79
页数:8
相关论文
共 58 条
[1]   Lack of a strong association between HLA class II, tumour necrosis factor and transporter associated with antigen processing gene polymorphisms and virological response to α-interferon treatment in patients with chronic hepatitis C [J].
Airoldi, A ;
Zavaglia, C ;
Silini, E ;
Tinelli, C ;
Martinetti, M ;
Asti, M ;
Rossini, A ;
Vangeli, M ;
Salvaneschi, L ;
Pinzello, G .
EUROPEAN JOURNAL OF IMMUNOGENETICS, 2004, 31 (06) :259-265
[2]  
Altobelli E, 1998, J PEDIATR ENDOCR MET, V11, P555
[3]   ANALYSIS OF HLA-DQ GENOTYPES AND SUSCEPTIBILITY IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
BAISCH, JM ;
WEEKS, T ;
GILES, R ;
HOOVER, M ;
STASTNY, P ;
CAPRA, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (26) :1836-1841
[4]   Genetic prediction of type 1 diabetes in a poputation with tow frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study) [J].
Buzzetti, R ;
Galgani, A ;
Petrone, A ;
Buono, MLD ;
Erlich, HA ;
Bugawan, TL ;
Lorini, R ;
Meschi, F ;
Multari, G ;
Pozzilli, P ;
Locatelli, M ;
Bottazzo, G ;
Di Mario, U .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2004, 20 (02) :137-143
[5]   HLA-DQA1 AND DQB1 GENE POLYMORPHISMS IN TYPE-I DIABETIC-PATIENTS FROM CENTRAL ITALY AND THEIR USE FOR RISK PREDICTION [J].
BUZZETTI, R ;
NISTICO, L ;
OSBORN, JF ;
GIOVANNINI, C ;
CHERSI, A ;
SORRENTINO, R .
DIABETES, 1993, 42 (08) :1173-1178
[6]   COMBINATIONS OF SPECIFIC DRB1, DQA1, DQB1 HAPLOTYPES ARE ASSOCIATED WITH INSULIN-DEPENDENT DIABETES-MELLITUS IN SARDINIA [J].
CUCCA, F ;
MUNTONI, F ;
LAMPIS, R ;
FRAU, F ;
ARGIOLAS, L ;
SILVETTI, M ;
ANGIUS, E ;
CAO, A ;
DEVIRGILIIS, S ;
CONGIA, M .
HUMAN IMMUNOLOGY, 1993, 37 (02) :85-94
[7]  
CUCCA F, 1996, HLA MHC GENES MOL FU, P383
[8]   HLA-DQ-BETA-SEQUENCE POLYMORPHISM AND GENETIC SUSCEPTIBILITY TO IDDM [J].
ERLICH, HA ;
BUGAWAN, TL ;
SCHARF, S ;
NEPOM, GT ;
TAIT, B ;
GRIFFITH, RL .
DIABETES, 1990, 39 (01) :96-103
[9]  
Ettinger R A, 2000, Rev Immunogenet, V2, P88
[10]  
Fernandes APM, 2002, ANN NY ACAD SCI, V958, P305